Top Markets
Coin of the day
Akili, Inc. Akili, Inc.

Akili, Inc.

AKLI
Rank in Stocks #27318
Akili, Inc. is a digital medicine enterprise focused on developing innovative... Akili, Inc. is a digital medicine enterprise focused on developing innovative digital therapies for individuals experiencing cognitive impairments. Its flagship product, EndeavorRx, stands out as a unique video game-based treatment that necessitates a physician's prescription and is specifically engineered to directly target and improve cognitive functioning. This company operates from its headquarters in Boston, Massachusetts.
Share Price
$0.432
Last synced: 2024-07-02
Market Cap
$33.63M
Change (1 day)
-0.25%
Change (1 year)
0.00%
Country
US
Trade Akili, Inc. (AKLI)

Category

P/S ratio for Akili, Inc. (AKLI)
P/S ratio as of 2026 TTM: 0
According to Akili, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Akili, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors